Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment
(marketscreener.com) CANTANHEDE, Portugal, Oct. 16, 2023 — Tilray Medical, a division of Tilray Brands, Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individua…
CANTANHEDE, Portugal, Oct. 16, 2023 (GLOBE NEWSWIRE) — Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis…